comparemela.com

Keros Therapeutics Presents Additional Clinical Data from its KER-012 Program and Preclinical Data from its KER-050 Program at the American Society of Bone and Mineral Research 2022 Annual Meeting

Keros Therapeutics Presents Additional Clinical Data from its KER-012 Program and Preclinical Data from its KER-050 Program at the American Society of Bone and Mineral Research 2022 Annual Meeting

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,American ,Jasbirs Seehra ,Deepankar Roy , ,Keros Therapeutics Inc ,Exchange Commission ,Mineral Research ,Company Quarterly Report On Form ,American Society Of Bone ,American Society ,Chief Executive Officer ,Healthy Postmenopausal Women ,Generally Well Tolerated ,Increased Biomarkers ,Bone Formation ,Bone Anabolic ,Novel Activin Receptor Type ,Improved Bone Loss ,Myelodysplastic Syndrome Mouse ,Keros Therapeutics ,Inc Keros ,Private Securities Litigation Reform Act ,Quarterly Report ,

comparemela.com © 2020. All Rights Reserved.